Mountain Pacific Investment Advisers Inc. ID Raises Stock Position in Teleflex Incorporated (NYSE:TFX)

Mountain Pacific Investment Advisers Inc. ID grew its holdings in Teleflex Incorporated (NYSE:TFXFree Report) by 1.1% during the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 78,958 shares of the medical technology company’s stock after acquiring an additional 835 shares during the period. Mountain Pacific Investment Advisers Inc. ID’s holdings in Teleflex were worth $19,687,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also recently made changes to their positions in TFX. Allworth Financial LP lifted its holdings in Teleflex by 332.3% in the 3rd quarter. Allworth Financial LP now owns 134 shares of the medical technology company’s stock worth $26,000 after purchasing an additional 103 shares in the last quarter. Lindbrook Capital LLC lifted its holdings in shares of Teleflex by 75.3% in the fourth quarter. Lindbrook Capital LLC now owns 135 shares of the medical technology company’s stock worth $34,000 after buying an additional 58 shares in the last quarter. Venturi Wealth Management LLC bought a new position in shares of Teleflex during the third quarter worth $27,000. Massmutual Trust Co. FSB ADV grew its stake in Teleflex by 418.5% during the fourth quarter. Massmutual Trust Co. FSB ADV now owns 140 shares of the medical technology company’s stock valued at $35,000 after acquiring an additional 113 shares in the last quarter. Finally, Covestor Ltd grew its stake in Teleflex by 305.6% during the third quarter. Covestor Ltd now owns 146 shares of the medical technology company’s stock valued at $29,000 after acquiring an additional 110 shares in the last quarter. Institutional investors own 95.62% of the company’s stock.

Analyst Upgrades and Downgrades

TFX has been the topic of several research analyst reports. StockNews.com cut shares of Teleflex from a “buy” rating to a “hold” rating in a research note on Friday, February 23rd. Truist Financial reduced their price objective on Teleflex from $270.00 to $265.00 and set a “hold” rating on the stock in a research note on Friday, February 23rd. JMP Securities reissued a “market outperform” rating and issued a $285.00 target price on shares of Teleflex in a report on Friday, February 23rd. Finally, Royal Bank of Canada reduced their price target on shares of Teleflex from $272.00 to $265.00 and set an “outperform” rating on the stock in a research report on Friday, February 23rd. Four analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. According to MarketBeat, Teleflex presently has an average rating of “Moderate Buy” and a consensus target price of $267.50.

View Our Latest Research Report on TFX

Teleflex Stock Performance

Shares of NYSE TFX opened at $206.71 on Friday. Teleflex Incorporated has a fifty-two week low of $177.63 and a fifty-two week high of $276.43. The company has a market cap of $9.74 billion, a price-to-earnings ratio of 27.45, a PEG ratio of 2.02 and a beta of 1.11. The business’s 50 day moving average price is $221.23 and its 200-day moving average price is $225.61. The company has a debt-to-equity ratio of 0.39, a quick ratio of 1.29 and a current ratio of 2.32.

Teleflex (NYSE:TFXGet Free Report) last released its quarterly earnings data on Thursday, February 22nd. The medical technology company reported $3.38 earnings per share for the quarter, topping analysts’ consensus estimates of $3.26 by $0.12. The company had revenue of $773.90 million during the quarter, compared to analyst estimates of $769.01 million. Teleflex had a net margin of 11.98% and a return on equity of 14.98%. The firm’s revenue for the quarter was up 2.1% compared to the same quarter last year. During the same period in the prior year, the firm earned $3.52 earnings per share. On average, sell-side analysts expect that Teleflex Incorporated will post 13.73 earnings per share for the current year.

Teleflex Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, March 15th. Shareholders of record on Friday, March 1st were issued a $0.34 dividend. The ex-dividend date of this dividend was Thursday, February 29th. This represents a $1.36 dividend on an annualized basis and a yield of 0.66%. Teleflex’s dividend payout ratio is presently 18.06%.

Insiders Place Their Bets

In other news, VP Cameron P. Hicks sold 7,401 shares of Teleflex stock in a transaction that occurred on Tuesday, March 5th. The shares were sold at an average price of $225.00, for a total value of $1,665,225.00. Following the transaction, the vice president now owns 10,050 shares of the company’s stock, valued at approximately $2,261,250. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. 1.43% of the stock is currently owned by corporate insiders.

About Teleflex

(Free Report)

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.

Further Reading

Want to see what other hedge funds are holding TFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teleflex Incorporated (NYSE:TFXFree Report).

Institutional Ownership by Quarter for Teleflex (NYSE:TFX)

Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.